Melinta Therapeutics Shows that Health-Related Quality-of-Life is higher in ABSSSI Patients Deemed Cured vs Improved after End of Treatment
09 avr. 2015 12h02 HE
|
Melinta Therapeutics
New Haven, CT, April 9, 2015 (GLOBE NEWSWIRE) -- Melinta Therapeutics today presented an evaluation of
Health-Related Quality-of-Life (HRQL) in acute bacterial skin and
skin structure infection...
NEMUS Bioscience, Inc. initiates anti-infective program with focus on MRSA
18 mars 2015 07h06 HE
|
Nemus Bioscience
COSTA MESA, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS) announced today that the company would begin studies concerning the medical utility of cannabinoids as...
ContraFect Corporation to Present at the 13th Annual BIO Investor Forum
30 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 30, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation Expands Senior Management Team
24 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 24, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation to Present at BioCentury's 21st Annual NewsMakers in the Biotech Industry Conference
19 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NEW YORK--(Marketwired - Sep 19, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on protein and antibody therapeutic products...
ContraFect Corporation's Universal Influenza Treatment Receives SBIR Funding
16 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 16, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation Announces Separation of Units Sold in IPO
09 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 9, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation to Present at the Rodman & Renshaw 16th Annual Healthcare Conference
03 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 3, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Showcases CF-301 at ICAAC 2014 Meeting in Washington, D.C.
02 sept. 2014 17h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 2, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Announces Exercise of Initial Public Offering Over-Allotment Option
27 août 2014 17h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Aug 27, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...